- Home
- ECX vs SLP Comparison
ECX vs SLP Comparison
Compare ECX & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECX
- SLP
- Stock Information
- Founded
- ECX 2017
- SLP 1996
- Country
- ECX China
- SLP United States
- Employees
- ECX N/A
- SLP N/A
- Industry
- ECX EDP Services
- SLP EDP Services
- Sector
- ECX Technology
- SLP Technology
- Exchange
- ECX Nasdaq
- SLP Nasdaq
- Market Cap
- ECX 589.5M
- SLP 675.9M
- IPO Year
- ECX N/A
- SLP 1997
- Fundamental
- Price
- ECX $2.19
- SLP $17.75
- Analyst Decision
- ECX Strong Buy
- SLP Buy
- Analyst Count
- ECX 1
- SLP 7
- Target Price
- ECX $3.20
- SLP $40.40
- AVG Volume (30 Days)
- ECX 2.7M
- SLP 571.6K
- Earning Date
- ECX 08-07-2025
- SLP 07-14-2025
- Dividend Yield
- ECX N/A
- SLP 0.34%
- EPS Growth
- ECX N/A
- SLP N/A
- EPS
- ECX N/A
- SLP 0.36
- Revenue
- ECX $805,604,079.00
- SLP $78,564,000.00
- Revenue This Year
- ECX $26.72
- SLP $27.66
- Revenue Next Year
- ECX $30.34
- SLP $6.75
- P/E Ratio
- ECX N/A
- SLP $49.29
- Revenue Growth
- ECX 19.98
- SLP 21.49
- 52 Week Low
- ECX $0.76
- SLP $16.72
- 52 Week High
- ECX $3.25
- SLP $44.33
- Technical
- Relative Strength Index (RSI)
- ECX 73.84
- SLP 27.94
- Support Level
- ECX $1.62
- SLP $16.78
- Resistance Level
- ECX $1.96
- SLP $18.95
- Average True Range (ATR)
- ECX 0.15
- SLP 0.86
- MACD
- ECX 0.05
- SLP 0.24
- Stochastic Oscillator
- ECX 86.86
- SLP 30.47
About ECX ECARX Holdings Inc. Ordinary shares
ECARX Holdings Inc is engaged in the sales of system-on-chip core modules, automotive computing platform products, and software stacks as well as the provision of research and development services in the People's Republic of China. The company's core products include infotainment head units, digital cockpits, vehicle chip-set solutions, a core operating system, and an integrated software stack. Beyond this, ECARX is developing a full-stack automotive computing platform. It is engaged in automotive intelligence and networking.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.